Search for: "Schering-Plough Corporation"
Results 21 - 40
of 100
Sorted by Relevance
|
Sort by Date
18 Dec 2013, 2:13 pm
The plaintiffs contend that Organon and Schering-Plough, among other things, failed to adequately design and manufacture NuvaRing and failed to adequately warn of the alleged increased risk of venous thromboembolism (“VTE”) posed by NuvaRing, and/or downplayed the risk of VTE. [read post]
21 Dec 2011, 6:01 pm
., Schering Plough Corp., Organon USA, Inc., N.V. [read post]
22 Mar 2018, 1:23 pm
Shortly thereafter Schering-Plough Corporation merged with Merck & Company, Inc., who kept Solis on in his same role for a year before firing him. [read post]
28 Dec 2009, 7:57 am
Schering-Plough recently merged with Merck, and is now known as Merck & Co.California's $21.3 million agreement is one of three settlements negotiated with Schering-Plough, collectively totaling $69 million, over falsely inflated drug prices. [read post]
22 Apr 2011, 10:51 am
Merck merged with Schering-Plough Corp. on Nov. 3, 2009, and, according to the complaint, had told PETA that they needed to prove ownership in Schering-Plough to be eligible. [read post]
23 Jul 2009, 6:00 am
Its parent company, Schering-Plough Corp., is located in Kenilworth, New Jersey. [read post]
27 Jan 2012, 4:00 pm
., Schering Plough Corporation, Organon Inc., and N.V. [read post]
14 Dec 2017, 5:30 am
Schering-Plough Corp., December 11, 2017, Patterson, A.). [read post]
10 Jan 2011, 11:00 am
Cain (the “Shareholders”), holders of eleven shares of defendant Schering-Plough Corporation (the “Company”), filed a shareholder derivative complaint against defendant Company for corporate mismanagement and wrongdoing in connection with the failure to make a timely disclosure of the results of a drug trial for one of Schering’s products called ENHANCE. [read post]
31 Jul 2012, 7:25 am
The plaintiffs are challenging settlements between Schering-Plough Corporation, the patent holder and manufacturer of K-Dur 20, and Upsher Smith Laboratories and ESI Lederle (“ESI”), which sought to market generic versions of the drug. [read post]
23 Apr 2007, 2:25 am
Schering-Plough Sued in N.J. for Marketing Drugs for Off-Label Uses A raft of lawsuits centered in New Jersey allege Schering-Plough Corp. offered bribes, kickbacks and other incentives to doctors to get them to prescribe its hepatitis and cancer drugs for uses not approved by the Food and Drug Administration Racial-Profiling Claim Gets Priority Over State's Attenuation Argument A criminal defendant is… [read post]
27 Jan 2012, 11:20 am
/Schering-Plough Fred Hassan 2003-2009 $189,352,324 IBM Louis V. [read post]
8 Dec 2009, 9:08 am
Sabatino Jr., former EVP and general counsel, Schering-Plough Michael F. [read post]
2 Dec 2009, 12:49 pm
EVP and general counsel, Schering-Plough. [read post]
24 May 2011, 1:51 pm
., Schering Plough Corporation, Organon Inc., and N.V. [read post]
10 Aug 2009, 7:19 am
Fosamax was sold by Schering-Plough Corporation, which is being bought by Merck & Co. [read post]
28 Feb 2011, 6:58 pm
Organon, which is a wholly owned subsidiary of Merck & Co., Inc. and is related to Organon USA, Inc. and Schering Plough Corporation. [read post]
18 Feb 2012, 9:11 am
., Organon Pharmaceuticals, Akzo Nobel NV and Schering-Plough Corporation as defendants. [read post]
14 Jul 2010, 7:53 am
Schering-Plough Healthcare Products Inc. v. [read post]
21 Jun 2007, 7:49 am
A federal judge in Beantown ruled that four Big Pharma companies — AstraZeneca, Schering-Plough and Bristol-Myers — engaged in unfair and deceptive trade practices regarding drug pricing. [read post]
